Ask the Expert

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Latest News

ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma

In patients with newly diagnosed multiple myeloma (MM) who are ineligible for high-dose chemotherapy and transplantation, adding daratumumab to bortezomib,...
Continue Reading

Cancer drug funding welcomed

Mark Wellington cherished the final years he spent with his wife after she was diagnosed with multiple myeloma. Now he...
Continue Reading

Newsletter: January 2020

Happy New Year to everybody. It was a very busy and productive year in 2019. Thanks to everyone who has...
Continue Reading

Myeloma NZ calls on Pharmac to make good on access deal

Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer...
Continue Reading

Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer

Media Release In a move welcomed by patient advocacy group Myeloma New Zealand, drug buying agency Pharmac has proposed to...
Continue Reading

Multiple Myeloma Research Review

Highlights include: • Once-weekly vs twice weekly carfilzomib for newly diagnosed MM • Negative trials for pembrolizumab in treatment naive and relapsed/refractory...
Continue Reading

Subscribe

Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.

Videos